Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.

ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, P Bedossa, A Geier, S Beckebaum, PN Newsome, D Sheridan, MY Sheikh, J Trotter, REGENERATE Study Investigators

Research output: Contribution to journalArticlepeer-review

231 Citations (Scopus)
Original languageEnglish
Pages (from-to)2184-2196
JournalLancet (London, England)
Publication statusPublished - Dec 2019

Cite this